深圳本地股活躍金證股份(600446.SH)漲停
格隆匯8月19日丨國務院發佈《關於支持深圳建設中國特色社會主義先行示範區的意見》指出:“支持深圳建設5G、人工智能、網絡空間科學與技術、生命信息與生物醫藥實驗室等重大創新載體,探索建設國際科技信息中心和全新機制的醫學科學院。”受此影響,深圳本地的人工智能概念股金證股份(600446.SH)漲停,報19.71元,成交10億元,漲停封單5.96萬手,涉資1.1億元,最新總市值168億元。深圳市人民政府官網顯示,人工智能、5G移動通信等七個技術領域被深圳列為新一代信息技術產業關鍵領域,而新一代信息技術產業又被深圳列為七大戰略新興產業之一。(行情來源:富途證券)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.